IBRX vs SYRE
Comparison between ImmunityBio Inc (IBRX, Company) and Spyre Therapeutics Inc (SYRE, Company).
Both IBRX and SYRE are from the Healthcare sector.
5-Year PerformanceIBRX has outperformed SYRE, delivering a return of -7.1% compared to -10.2%
IBRX vs SYRE - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
IBRX vs SYRE - Historical Returns
Returns include dividend reinvestment.
IBRX vs SYRE - Annual Returns (2015 - 2026)
Returns include dividend reinvestment.
| Year | IBRX | SYRE |
|---|---|---|
| 2026 | +282.67% | +233.78% |
| 2025 | -22.96% | +37.36% |
| 2024 | -51.15% | +8.79% |
| 2023 | +5.24% | +104.27% |
| 2022 | -32.67% | -90.57% |
| 2021 | -55.72% | -44.51% |
| 2020 | +236.62% | +1.55% |
| 2019 | +191.54% | -4.98% |
| 2018 | -73.52% | +39.22% |
| 2017 | -24.03% | +18.38% |
| 2016 | -63.68% | -55.48% |
| 2015 | -49.97% | N/A |
IBRX vs SYRE Drawdown Comparison
The maximum drawdown for IBRX was -97.14%, occurring on Jun 10, 2019. Recovery took 1399 trading sessions.
The maximum drawdown for SYRE was -99.11%, occurring on Jun 21, 2023. This drawdown has not yet recovered.
The current IBRX drawdown is -81.70%. The current SYRE drawdown is -65.95%.
| Rank | IBRX | SYRE |
|---|---|---|
| #1 | -97.14% Jul 29, 2015 - Feb 18, 2021 | -99.11% Apr 8, 2016 - Jun 21, 2023 |
| #2 | -97.03% Feb 22, 2021 - Oct 19, 2023 | N/A |
Correlation
Correlation between IBRX and SYRE is 0.24 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks